COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future

Patients with cancer demonstrate an increased vulnerability for infection and severe disease by SARS-CoV-2, the causative agent of COVID-19. Risk factors for severe COVID-19 include comorbidities, uncontrolled disease, and current line of treatment. Although COVID-19 vaccines have afforded some leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Victoria G, Teh, Benjamin W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
COVID-19 Vaccination Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401617/
https://www.ncbi.nlm.nih.gov/pubmed/37539765
http://dx.doi.org/10.1093/infdis/jiad174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401617/
https://www.ncbi.nlm.nih.gov/pubmed/37539765
http://dx.doi.org/10.1093/infdis/jiad174

Ejemplares similares